Concepedia

Author

Kiriko Kurokawa

Sumitomo Dainippon Pharma (Japan)

Also Known As

Kiriko Kurokawa

10

Publications

290

Citations

7

H-Index

19

Concepts

All Affiliations

Sumitomo Dainippon Pharma (Japan)
KK

About

Kiriko Kurokawa is an author at Sumitomo Dainippon Pharma (Japan) specializing in medicinal chemistry, drug discovery, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

190

2

Natural Sciences

3

3

170

3

Biochemistry

3

3

170

4

Engineering

1

1

29

5

Biomolecular Engineering

1

1

29

Kiriko Kurokawa

×

6

Publications

280

Citations

6

H-Index

YearCitations

New Type of Metalloproteinase Inhibitor:  Design and Synthesis of New Phosphonamide-Based Hydroxamic Acids

Masaaki Sawa, Takao Kiyoi, Kiriko Kurokawa,

Journal of Medicinal Chemistry

2002

119

New Strategy for Antedrug Application:  Development of Metalloproteinase Inhibitors as Antipsoriatic Drugs

Masaaki Sawa, Takako Tsukamoto, Takao Kiyoi,

Journal of Medicinal Chemistry

2002

49

A Highly Practical Synthesis of Sulfated Lewis X:  One-Pot, Two-Step Glycosylation Using “Armed/Disarmed” Coupling and Selective Benzoylation and Sulfation

Takahiro Tsukida, Masahiro Yoshida, Kiriko Kurokawa,

The Journal of Organic Chemistry

1997

43

Studies on Selectin Blockers. 5. Design, Synthesis, and Biological Profile of Sialyl Lewis x Mimetics Based on Modified Serine−Glutamic Acid Dipeptides

Takahiro Tsukida, Yasuyuki Hiramatsu, Hideki Tsujishita,

Journal of Medicinal Chemistry

1997

29

Discovery of selective phosphonamide-based inhibitors of tumor necrosis factor-α converting enzyme (TACE)

Masaaki Sawa, Kiriko Kurokawa, Yoshimasa Inoue,

Bioorganic & Medicinal Chemistry Letters

2003

22

Studies on Selectin Blockers. 7. Structure−Activity Relationships of Sialyl Lewis X Mimetics Based on Modified Ser-Glu Dipeptides

Takahiro Tsukida, H. Moriyama, Kiriko Kurokawa,

Journal of Medicinal Chemistry

1998

18

Page 1